SCHEMBL4633700

SCHEMBL4633700

CC(C)Oc1ccc(C#Cc2cccc(C(=O)O)c2)cc1C(=O)N[C@@H](CO)Cc1c[nH]c2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.44
EPHX2 P34913 1/20 0.44
MMP9 P14780 2/20 0.42
HDAC3 O15379 5/20 0.42
HDAC4 P56524 5/20 0.42
HDAC1 Q13547 5/20 0.42
HDAC7 Q8WUI4 5/20 0.42
HDAC2 Q92769 5/20 0.42
HDAC10 Q969S8 5/20 0.42
HDAC11 Q96DB2 5/20 0.42
HDAC8 Q9BY41 5/20 0.42
HDAC6 Q9UBN7 5/20 0.42
HDAC9 Q9UKV0 5/20 0.42
HDAC5 Q9UQL6 5/20 0.42
CTSL P07711 1/20 0.42
MMP2 P08253 1/20 0.41
TACR1 P25103 5/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
ITGB2 P05107 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4634688 0.94 ALOX5 (0.44) ALOX5EPHX2MMP9HDAC3HDAC4
SCHEMBL4736756 0.94 MMP9 (0.49) MMP9HDAC3HDAC4HDAC1HDAC7
SCHEMBL13945806 0.94 MMP9 (0.47) MMP9HDAC3HDAC4HDAC1HDAC7
SCHEMBL14069723 0.93 ALOX5 (0.45) ALOX5EPHX2MMP9HDAC3HDAC4
SCHEMBL4632726 0.92 ALOX5 (0.46) ALOX5EPHX2MMP9HDAC3HDAC4
SCHEMBL4633723 0.91 MAPT (0.44) MMP9HDAC3HDAC4HDAC1HDAC7
SCHEMBL4633762 0.91 MMP9 (0.42) MMP9HDAC3HDAC4HDAC1HDAC7
SCHEMBL4735166 0.91 MMP9 (0.42) MMP9HDAC3HDAC4HDAC1HDAC7
SCHEMBL4803110 0.91 MMP9 (0.41) ALOX5EPHX2MMP9HDAC3HDAC4
SCHEMBL4738991 0.91 MMP9 (0.41) ALOX5EPHX2MMP9HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221195-A1 1,2-DIARYLACETYLENE DERIVATIVES OF ACYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-09-11 US claimed
EP-1932831-A1 1,2-Diarylacetylene Derivatives of Acyltryptophanols Bayer Schering Pharma Aktiengesellschaft (DE) 2008-06-18 EP claimed
US-20080221195-A1 1,2-DIARYLACETYLENE DERIVATIVES OF ACYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-09-11 US disclosed
US-20080221195-A1 1,2-DIARYLACETYLENE DERIVATIVES OF ACYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-09-11 US disclosed
EP-1932831-A1 1,2-Diarylacetylene Derivatives of Acyltryptophanols Bayer Schering Pharma Aktiengesellschaft (DE) 2008-06-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221195-A1 1,2-DIARYLACETYLENE DERIVATIVES OF ACYLTRYPTOPHANOLS FSHR, GNRHR, TPH1 ALOX5 911/4885EPHX2 3114/4885MMP9 3664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.